Edition:
United Kingdom

Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
24 Jun 2019
Change (% chg)

-- (--)
Prev Close
$0.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
287,742
52-wk High
$6.80
52-wk Low
$0.72

About

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition,... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $43.07
Shares Outstanding(Mil.): 20.12
Dividend: --
Yield (%): --

Financials

  PULM.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -1.37 -- --
ROI: -104.24 8.90 13.82
ROE: -122.80 10.04 15.24

Earnings vs. Estimates